Syntonix Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Syntonix Pharmaceuticals Ownership

Who owns Syntonix Pharmaceuticals?

Syntonix Pharmaceuticals is owned by Biogen. It was acquired on February 1, 2007.

Was Syntonix Pharmaceuticals formerly PE-backed?

Yes. Syntonix Pharmaceuticals was formerly owned by 2 private investors.

Syntonix Pharmaceuticals Business Overview

Where is Syntonix Pharmaceuticals headquartered?

Syntonix Pharmaceuticals is headquartered in Waltham, Massachusetts.

What sector is Syntonix Pharmaceuticals in?

Syntonix Pharmaceuticals is a life science company.

When was Syntonix Pharmaceuticals founded?

Syntonix Pharmaceuticals was founded in 1997.

Life Science M&A Summary in 2007

Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2007. The largest life science acquisition in 2007 was Organon BioSciences N.V. - which was acquired by Schering-Plough for $12.4B.

Join Mergr to view all 131 acquisitions of life science companies in 2007, including 29 acquisitions by private equity firms, and 102 by strategics.

Syntonix Pharmaceuticals, Inc.

9 Fourth Avenue,
Waltham, Massachusetts 02451
United States,
(781) 547-6000
www.syntnx.com

Syntonix Pharmaceuticals, Inc. is a needle-free drug delivery company utilizing the FcRn receptor to transport macromolecules across epithelial barriers in the central airway and into circulation.


 Subscribe to unlock this and 207,877
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.